Addiction

Article	Citations
Commentary on Savinkina et al.: Reforming drug ‘detox’ centers—what will it entail and where do we begin?	124
Domestication of drinking: a survey study of changes in types of drinking occasions during periods of increasing and decreasing alcohol consumption in the 2000s in Finland	110
Issue Information	105
Co‐use measurement is also required in treatment interventions	99
Issue Information	93
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review	84
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	75
The effectiveness of workplace interventions for the prevention of alcohol use: A meta‐analysis	75
Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder	73
Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial	58
Harm to others from alcohol or other drug use is an inclusive frame for an important dimension: a response to Wilkinson & Ritter	57
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis	55
How does the influence of the cannabis industry differ from that of alcohol and tobacco?	55
Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	53
Do not conflate debates on regulating therapeutic use of psychotropic substances with those on the legalization of their non‐therapeutic use	52
Transitions to polysubstance use: Prospective cohort study of adolescents in Australia	48
Misleading conclusion from limited research approach: Comment on Manthey et al. ‘Restricting alcohol marketing to reduce alcohol consumption: A systematic review of the empirical evidence for o	48
Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2‐year longitudinal study	47
Co‐action and changes in alcohol use during a smoking cessation attempt	47
Commentary on Chai et al: Drug use, self‐harm, suicide, and use of registry data in epidemiological research	46
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	46
Referees	43
Does the decline in Swedish adolescent drinking persist into early adulthood?	43
Issue Information	43
Commentary on Kunas et al.: Hijacked brain reward systems—how methodological advances can help to bridge gaps in the translational science pipeline	43

When should we conduct large‐scale evaluations?	42
Commentary on Brummer et al.: When using screening tools, it is important to be aware of what you are screening for	42
Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	42
Prenatal areca nut consumption: overlooked aspects of a widely embraced habit	41
Minimum unit pricing and the messiness of evidence‐based policy	41
The ability of the UK population surveys to capture the true nature of the extent of gambling‐related harm	40
Issue Information	40
Reduction in smoking prevalence and e‐cigarettes: an English exception?	40
What on‐line searches tell us about public interest and potential impact on behaviour in response to minimum unit pricing of alcohol in Scotland	39
New synthetic drugs require new policies	38
Commentary on Hill et al.: Breaking down barriers—increasing access to lifesaving opioid use disorder medications to save lives	38
Promoting addiction science after Brexit—what can Addiction and SSA do and what does UK government need to do?	37
Issue Information	37
Issue Information	37
Issue Information	36
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	35
Peer‐ and web‐based interventions for risky drinking among US National Guard members: Mission Strong randomized controlled trial	35
Commentary on Perry et al.: New means, new measures—without discarding all the previous ones!	34
Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020	34
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	34
Issue Information	34
Commentary on Edwards et al.: Alcohol use disorder—a different impact in young adulthood than later?	34
Redefining and categorizing emergency medical service opioid‐related incidents in Massachusetts	33
Cannabis: Global Histories by Lucas Richert and James H. Mills, editors	33
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	33
Substance use treatment completion and criminal justice system contact in Chile: A retrospective, linked data cohort study	33
Future Directions for the International Cannabis Toolkit (iCannToolkit)	33
Safety of e‐cigarettes and nicotine patches as stop‐smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E‐cigarettes and Patches (PREP) randomized controlled trial	32
Nitrous oxide: The label ‘potentially addictive’ may do more harm than good	31
Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone	30
Strengthening oversight and integrity: The multi‐faceted role of centralized player tracking systems in gambling	30
Evidence for a hijacked brain reward system but no desensitized threat system in quitting‐motivated smokers: An fMRI study	30
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	30
Behavioral counseling and abstinence‐contingent take‐home buprenorphine in general practitioners’ offices in Malaysia: a randomized, open‐label clinical trial	29
Addiction Lives: Robert West	29
Virtual contingency management, what is it worth and who will pay for it?	29
Closing the research‐to‐implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities	28
Addiction Lives: Maggie Brady	27
Commentary on Rivera‐Aguirre et al.: What are the effects of cannabis legalization on youth use? It may depend on what you mean by ‘legalization’	27
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	27
GLP‐1R agonist medications for addiction treatment	26
Effects of a minimal‐guided on‐line intervention for alcohol misuse in Estonia: a randomized controlled trial	26
Issue Information	26
The shape of gambling risk‐curves for frequency, expenditure and proportion of income in Australia	26
Taming cannabis: drugs and empire in nineteenth century France by David A. Guba Jr.	26
Will Australia's tightened prescription system reduce nicotine vaping among young people?	25
Systematic review and meta‐analyses of cytisine to support tobacco cessation	25
Will Australia's tightened prescription system reduce nicotine vaping among young people?	25
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	25
Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map	25

Predictors of alcohol and other drug treatment completion among young people accessing residential and community‐based treatment: A retrospective analysis of routinely collected service data	25
Effects of e‐cigarette use on mental health among youths: quasi‐experimental evidence from Canada	24
The iCannToolkit: a tool to embrace measurement of medicinal and non‐medicinal cannabis use across licit, illicit and cross‐cultural settings	24
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	24
Issue Information	24
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial	24
Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile	24
	23
An evaluation of naloxone transit for opioid overdose using drones: A case study using real‐world coroner data	23
Cost‐effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico	23
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	23
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	23
Commentary on Beard et al.: Using survey data to test the hypothesis that e‐cigarettes are a gateway to cigarette smoking in youth	23
Impact of vaping restrictions in public places on smoking and vaping in the United States—evidence using a difference‐in‐differences approach	23
Effects of a brief alcohol intervention addressing the full spectrum of drinking in an adult general population sample: a randomized controlled trial	23
Issue Information	23
Influence of vaccination on adverse health outcomes after SARS‐CoV‐2 infection among individuals with alcohol use disorder: a population‐based study	22
Issue Information	22
Issue Information	22
Drinking motives, personality traits and life stressors—identifying pathways to harmful alcohol use in adolescence using a panel network approach	21
Issue Information	21
Social and structural determinants of injection drug use‐associated bacterial and fungal infections: A qualitative systematic review and thematic synthesis	21
Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study	21
Why do we focus on the exception and not the rule? Examining the prevalence of mono‐ versus polysubstance use in the general population	21
Addiction: A treatise from 1561	21
Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions	20
Cigarette pack size and consumption: a randomized cross‐over trial	20
The association of lowered alcohol prices with birth outcomes and abortions: A population‐based natural experiment	20
Commentary on Staff et al.: Should smoke‐free areas be made vape‐free?	20
Understanding the mechanisms of change in social norms around tobacco use: A systematic review and meta‐analysis of interventions	20
Commentary on Kumar et al.: The importance of conceptual clarity and alignment between constructs and measurements in social cognition research in addiction	20
Commentary on Victor et al. : Preventing overdose deaths following release from incarceration—context is crucial	19
Commentary on Loud et al.: Reconsidering nicotine dependence in adults	19
Commentary on Lo‐Ciganic et al.: The importance of evidence‐based clinical and policy approaches to reduce opioid harms	19
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	19
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	19
‘A man can only be truly known in drunkenness and war.’ An anthropological perspective on alcohol use during the Portuguese Colonial War	19
Overestimation of alcohol consumption norms as a driver of alcohol consumption: a whole‐population network study of men across eight villages in rural, southwestern Uganda	19
	18
Issue Information	18
Longer‐term impacts of trading restrictions on alcohol‐related violence: insights from New South Wales, Australia	18
Does the preparation for intravenous administration affect the composition of heroin injections? A controlled laboratory study	18
Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society	18
All alcohol exposure counts ‐ testing parental, older sibling, best friend and peer exposure on young adolescent drinking in a seven‐wave longitudinal study	18
Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact	18
Use of the BACtrack Skyn alcohol biosensor: Practical applications for data collection and analysis	17
Socio‐economic inequalities in smoking and drinking in adolescence: Assessment of social network dynamics	17
Issue Information	17
Commentary on Kelly et al.: The struggle to define or be defined	17
An N‐of‐1 study of daily alcohol consumption following minimum unit pricing implementation in Scotland	17
Recognizing the complexities of co‐prescriptions and life‐style factors in opioid agonist treatment: A response from Eleni Domzaridou, Matthew J. Carr, Tim Millar, Roger T. Webb and Darren M. Ashcroft	17
Coordinating cannabis data collection globally: Policy implications	17
Commentary on Keller‐Hamilton et al. : Oral nicotine pouches provide a less controversial route for tobacco harm reduction than electronic cigarettes	17
Studying harm from others’ illicit drug use—can stigma really be avoided?	17
Polygenic score for cigarette smoking is associated with ever electronic‐cigarette use in a college‐aged sample	16
Stigma and gaming disorder: should we take a ‘glass half full’ or ‘glass half empty’ perspective?	16
Gabapentinoids: repeating mistakes of the past?	16
Accurate and sufficient measurement of cannabis and tobacco co‐use: agreement, consensus and the path forward	16
Affected other interventions: a systematic review and meta‐analysis across addictions	16
Behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India and Pakistan: A pilot randomized controlled trial	16
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	16
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	16
Coordination, framing and innovation: the political sophistication of public health advocates in Ireland	16
Naloxone administration—no balance without titration	16
Reducing barriers to the hepatitis C care cascade in prison via point‐of‐care RNA testing: a qualitative exploration of men in prison using an integrated framework	16
Effectiveness of training stop‐smoking advisers to deliver cessation support to the UK national proposed standard versus usual care in Malaysia: a two‐arm cluster‐randomized controlled trial	16
An Addiction series on regional perspectives on addiction‐related problems	16
Commentary on Pessar et al.: ‘Downscaling’ United States state cannabis policy to investigate environmental and social impacts on cannabis use	15
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	15
Commentary on Stam et al.: The substantial and dynamic contribution of opioid potency to total overdose risk	15
Use of disposable e‐cigarettes among youth who vape in Canada, England and the United States: Repeat cross‐sectional surveys, 2017–2023	15
The risks of misclassifying addictive food substances as non‐addictive	15
Alcohol use as a predictor of intimate partner violence in emerging adulthood: A dyadic daily diary investigation	15
Mapping consumptions and market size of cocaine, amphetamine and MDMA through wastewater analysis: A Dutch case study	15
Public health considerations about tetrahydrocannabinol‐infused beverages	15
Cannabis use in sub‐Saharan Africa: A systematic review and meta‐analysis	15
Maternal and child genetic liability for smoking and caffeine consumption and child mental health: an intergenerational genetic risk score analysis in the ALSPAC cohort	15
	15
Why it is important to conduct gambling research that is fair and free from conflicts of interest	15
Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014–2021	15

Commentary on Brennan et al.: Pros and cons of minimum unit price for alcohol	15
A first pass, using pre‐history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems, 1970s–c. 2018	15
What can we learn from the history of research on psychedelic drugs in the addictions?	15
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	14
Alcohol consumption in India: a systematic review and modelling study for sub‐national estimates of drinking patterns	14
Prevalence of use and real‐world effectiveness of smoking cessation aids during the COVID‐19 pandemic: a representative study of smokers in England	14
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial	14
Scandalous decisions: explaining shifts in UK medicinal cannabis policy	14
A critique of the Australian National Health and Medical Research Council CEO statement on electronic cigarettes	14
Harm perceptions of nicotine‐containing products and associated sources of information in UK adults with and without mental ill health: A cross‐sectional survey	14
Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta‐analysis of its follow‐up effects	14
The efficacy and tolerability of pharmacologically active interventions for alcohol‐induced hangover symptomatology: a systematic review of the evidence from randomised placebo‐controlled trials	14
The old and familiar meets the new and unknown: patient and clinician perceptions on e‐cigarettes for smoking reduction in UK general practice, a qualitative interview study	14
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	14
US tobacco companies selectively disseminated hyper‐palatable foods into the US food system: Empirical evidence and current implications	14
Non‐alcoholic beverage consumption among US adults who consume alcohol	14
Changes in drinking days among United States adults during the COVID‐19 pandemic	14
Alcohol‐specific inhibition training in patients with alcohol use disorder: a multi‐centre, double‐blind randomized clinical trial examining drinking outcome and working mechanisms	14
How substance use prevention research gets used in United States federal policy	14
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	14
Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study	14
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	13
How do people quit smoking using e‐cigarettes? A mixed‐methods exploration of participant smoking pathways following receiving an opportunistic e‐cigarette‐based smoking cessation intervention	13
Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers	13
The National Academy of Sciences ‘Clearing the Smoke: assessing the Science Base for tobacco harm reduction’. Washington DC, National Academy Press, 2001	13
Hazardous and harmful alcohol use in the Northern Territory, Australia: the impact of alcohol policy on critical care admissions using an extended sampling period	13
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	13
Mortality in substance‐induced psychosis: a register‐based national cohort study	13
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	13
Characteristics and ingredients of disposable ‘Elfbar’ e‐cigarettes sold in the United States and the United Kingdom	13
Prevalence of pharmacotherapy for attention‐deficit/hyperactivity disorder and prescription stimulant misuse: A national study of US college students	13
Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study	13
Insights from biosurveillance: non‐fatal opioid overdoses in Rhode Island 2019–21	13
Disentangling the messiness of natural experiments to evaluate public policy	13
Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study	13
Commentary on Chambers et al.: Investigating the use of peer support services in substance use disorders treatment	13
Disposable e‐cigarettes: Prevalence of use in Germany from 2016 to 2023 and associated user characteristics	13
Artificial intelligence‐based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine‐type stimulant use disorder	13
Incident psychotic experiences following self‐reported use of high‐potency cannabis: Results from a longitudinal cohort study	13
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	13
Classifying alcohol control policies enacted between 2000 and 2020 in Poland and the Baltic countries to model potential impact	13
The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre‐menstrual dysphoric disorder	13
Cannabis and sport: A World Anti‐Doping perspective	12
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four‐Country survey (2002–14)	12
The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks	12
Prescribing psychologists: Forgotten providers in the battle against opioid use disorder	12
Trends and projection in the proportion of (heavy) cannabis use in Germany from 1995 to 2021	12
Does heroin‐assisted treatment reduce crime? A review of randomized‐controlled trials	12
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia,	12
The environmental impact of tobacco products: Time to increase awareness and action	12
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID‐19	12
Alcohol: No Ordinary Commodity—a summary of the third edition	12
Alcohol consumption trajectories over the Australian life course	12
Casino accessibility and suicide: A county‐level study of 50 US states, 2000 to 2016	12
Motivational interviewing and problem‐solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: A randomized controlled trial to assess the impact on alcoho	12
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	12
Concurrent validity of the Alcohol Purchase Task for measuring the reinforcing efficacy of alcohol: an updated systematic review and meta‐analysis	12
Does a local Alcohol Health Champion programme have a measurable impact on health and crime outcomes? A natural experiment evaluation of Communities in Charge of Alcohol (CICA) based on triangulation	12
Predictors of early and sustained cessation of heavy drinking over 5 years among adult primary care patients	12
Integrated care van delivery of evidence‐based services for people who inject drugs: A cluster‐randomized trial	12
Cutting down, quitting and motivation to stop smoking by self‐reported COVID‐19 status: Representative cross‐sectional surveys in England	12
What lessons from Norway's experience could be applied in the United States in response to the addiction and overdose crisis?	11
Experimental manipulations of behavioral economic demand for addictive commodities: a meta‐analysis	11
Society for the Study of Addiction Annual Conference 2024	11
Issue Information	11
Abuse‐deterrent extended‐release oxycodone and risk of opioid‐related harm	11
The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment	11
Rare but relevant series	11
Correction to “How do we determine the impact of e‐cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor”	11
Brain structural covariance network differences in adults with alcohol dependence and heavy‐drinking adolescents	11
Drug Use for Grown‐Ups: Chasing Liberty in the Land of Fear by Carl L. Hart	11
Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021	11
A systematic review and meta‐analysis of the relationship between youth drinking, self‐posting of alcohol use and other social media engagement (2012–21)	11
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	11
Correction to “The need for a comprehensive framework”	11
	11
Evaluation of monitoring youth exposure to alcohol advertising on cable television, United States 2016–19	11
Clinical management of the alcohol withdrawal syndrome	11
Prenatal smoking, alcohol and caffeine exposure and maternal‐reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic ris	10
Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned	10
Association between genetic risk of alcohol consumption and alcohol‐related morbidity and mortality under different alcohol policy conditions: Evidence from the Finnish alcohol price reduction of 2004	10
Craving modulates attentional bias towards alcohol in severe alcohol use disorder: An eye‐tracking study	10
How research and policy can shape driving under the influence of cannabis	10
Outcome class imbalance and rare events: An underappreciated complication for overdose risk prediction modeling	10
Roles of parental smoking and family structure for the explanation of socio‐economic inequalities in adolescent smoking	10
Up‐scheduling and codeine supply in Australia: analysing the intervention and outliers	10
	10
Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference‐in‐differences analysis of a pay‐for‐performance scheme in England	10
Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study	10
The EVALI outbreak makes a strong case for better regulation of all vaporizer products	10
Issue Information	10
Commentary on Booth et al.: Measuring the health burden of homelessness	10
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	10
From Dark Paradise to limbic capitalism	10
Issue Information	10